GenScript’s Post

Dive into innovation at TIDES 2024! Join us as we unveil groundbreaking insights in our breakfast spotlight presentation "Harnessing RNA to Simplify and Advance Gene Therapy" and our two posters, "Neoantigen vaccines: A promising cancer therapy" and "Integrated novel IVT RNA platforms to accelerate research and therapeutics development." Don't miss the chance to connect with our team! #TIDES2024 #oligonucletoide #peptide #genomeediting #mRNA

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer: https://lnkd.in/g98Pra2a

Embrace the era of certainty with Digital PCR! Elevate your research with the precision and sensitivity of dPCR for higher reproducibility across various therapeutic areas like Cell and Gene Therapy, Oncology, Monoclonal Antibodies, Vaccine development and more. Connect with us to learn more about how dPCR can help you with your next breakthrough discovery: https://hubs.ly/Q02Gn_-00 #ClinicalResearch #Genomics #DigitalPCR

Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer https://lnkd.in/geyErP4P Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA and Tecentriq in ES-SCLC Patients AUSTIN, Texas , Dec. 16, 2024 /PRNewswire/ [...]

Explore DNA methylation and its intricate role in cancer, where dysregulation of 5-methylcytosine (5mC) impacts gene regulation. Aberrant methylation patterns in CpG dinucleotides contribute to tumor suppressor gene silencing and oncogene activation. Seraseq® Methylated and Unmethylated ctDNA Mutation Mixes provide unparalleled insight into CpG methylation status, revolutionizing cancer research and personalized treatment approaches. Read our blog and discover the potential of DNA methylation in cancer diagnostics and therapy: https://hubs.ly/Q02vLmck0 #Methylation #GeneRegulation #DNAModification #CancerResearch #Epigenetics

The latest edition of The Dose covers the American Society of Hematology's 2024 Annual Meeting, highlighting the most impactful results presented during the recent conference. We review pre-clinical evidence supporting a novel ultrasound-mediated gene delivery mechanism, Phase 3 trial results for a novel gene therapy treating sickle cell disease, and the implications of Merck's presentations on trials spanning its robust hematology portfolio. Additionally, we explore efforts from Johnson & Johnson, BeiGene, and Eli Lilly to expand their footprint in hematology, with the latest results from clinical trials evaluating new applications for their existing treatments.  #ASH2024 #Hematology #HealthcareInnovation #AmericanSocietyofHematology #OncologyResearch #AryaConsultingPartners #TeamArya

RNA-Seq performs a comprehensive assessment of gene expression pathways, implicated in cancer development, that is vital for identifying personalized treatment options for patients. Learn how Labcorp's OmniSeq INSIGHT provides insights that can pave the way for more targeted therapies: https://lnkd.in/gg9Kwgq2

The FDA has granted accelerated approval to zenocutuzumab-zbco (Bizengri) for patients with advanced pancreatic cancer harboring an NRG1 gene fusion. This news is especially exciting given it's the first systemic therapy of its kind for this gene group. For a disease with a survival rate of just 13%, this news represents more than just a treatment; it's a step toward giving patients more time and a better quality of life, while underscoring the importance of continued investment in bold solutions for this disease. Read more: https://bit.ly/4fu5BZn

RNA-Seq performs a comprehensive assessment of gene expression pathways, implicated in cancer development, that is vital for identifying personalized treatment options for patients. Learn how Labcorp's OmniSeq INSIGHT provides insights that can pave the way for more targeted therapies: https://lnkd.in/gHPWAnN4

RNA-Seq performs a comprehensive assessment of gene expression pathways, implicated in cancer development, that is vital for identifying personalized treatment options for patients. Learn how Labcorp's OmniSeq INSIGHT provides insights that can pave the way for more targeted therapies: https://lnkd.in/g9cu4cE6